Laura Lupini
- Cancer Research top 2%
- MicroRNA in disease regulation 17
- Cancer-related molecular mechanisms research 7
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 6
- Circular RNAs in diseases 6
- RNA Research and Splicing 5
- RNA modifications and cancer 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 5
- Pathology and Forensic Medicine top 10%
-
- Immunodeficiency and Autoimmune Disorders 4
- Co-authors
- Massimo NegriniManuela FerracinBarbara ZagattiElisa CallegariAngelo VeroneseCristian BassiCarlo M. CroceFabio Corrà
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Laura Lupini
32 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 964
- Molecular Biology 1.1k
- Genetics 81
- Pathology and Forensic Medicine 136
- Oncology 155
Countries citing papers authored by Laura Lupini
This map shows the geographic impact of Laura Lupini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lupini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lupini more than expected).
Fields of papers citing papers by Laura Lupini
This network shows the impact of papers produced by Laura Lupini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lupini. The network helps show where Laura Lupini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Lupini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 23 | |
| 5 | 2019 | 21 | |
| 6 | 2018 | 10 | |
| 7 | 2018 | 16 | |
| 8 | 2018 | 1 | |
| 9 | AN EXTENSIVE MOLECULAR CYTOGENETIC CHARACTERIZATION IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA IDENTIFIES KARYOTYPE ABERRATIONS AND TP53 DISRUPTION AS PREDICTORS OF OUTCOME AND CHEMOREFRACTORINESS | 2017 | 1 |
| 10 | 2017 | 1 | |
| 11 | 2016 | 6 | |
| 12 | 2016 | 27 | |
| 13 | 2016 | 3 | |
| 14 | 2014 | 74 | |
| 15 | 2013 | 71 | |
| 16 | 2013 | 43 | |
| 17 | 2012 | 201 | |
| 18 | 2010 | 182 | |
| 19 | 2010 | 88 | |
| 20 | 2009 | 205 |
About Laura Lupini
Laura Lupini is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (7 papers), RNA Interference and Gene Delivery (6 papers), Circular RNAs in diseases (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), RNA Research and Splicing (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (964 citations), Molecular Biology (1.1k citations) and Genetics (81 citations). Laura Lupini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Negrini, Manuela Ferracin, Barbara Zagatti, Elisa Callegari, Angelo Veronese, Cristian Bassi, Carlo M. Croce, Fabio Corrà, Silvia Sabbioni and Elena Saccenti.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.